Cargando…

Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer

BACKGROUND: We determined factors associated with morbidity and outcomes of a series of non-small cell lung cancer (NSCLC) patients treated with dose-escalated chemoradiotherapy at the University of Pittsburgh Lung Cancer Program. METHODS AND MATERIALS: The records of 170 stage III NSCLC patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernard, Mark E., Glaser, Scott M., Gill, Beant S., Beriwal, Sushil, Heron, Dwight E., Luketich, James D., Friedland, David M., Socinski, Mark A., Greenberger, Joel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253386/ https://www.ncbi.nlm.nih.gov/pubmed/28168163 http://dx.doi.org/10.3389/fonc.2017.00001

Ejemplares similares

One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review
por: Sutera, Philip Anthony, et al.
Publicado: (2017)

Reddit and Radiation Therapy: A Descriptive Analysis of Posts and Comments Over 7 Years by Patients and Health Care Professionals
por: Thomas, Joel, et al.
Publicado: (2019)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina
por: Beriwal, Sushil, et al.
Publicado: (2008)

The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation
por: Iarrobino, Nick A., et al.
Publicado: (2018)

Exceptional Eight-year Response to Stereotactic Radiosurgery Monotherapy for Multiple Brain Metastases
por: Kalash, Ronny, et al.
Publicado: (2017)

Utilizing clinical pathways and web-based conferences to improve quality of care in a large integrated network using breast cancer radiation therapy as the model
por: Chen, Katherine S., et al.
Publicado: (2018)

Definitive Chemoradiation With Dose Escalation for Locally Advanced Gastric Cancer: Case Studies
por: Anthony, Michelle, et al.
Publicado: (2020)

What Do Patients Think About Their Radiation Oncologists? An Assessment of Online Patient Reviews on Healthgrades
por: Prabhu, Arpan V, et al.
Publicado: (2018)

Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014)

Salvage Stereotactic Body Radiotherapy for Locally Recurrent Non-Small Cell Lung Cancer after Sublobar Resection and I(125) Vicryl Mesh Brachytherapy
por: Gill, Beant S., et al.
Publicado: (2015)

Early clinical experience with varian halcyon V2 linear accelerator: Dual‐isocenter IMRT planning and delivery with portal dosimetry for gynecological cancer treatments
por: Kim, Hayeon, et al.
Publicado: (2019)

Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality!
por: Patil, Vijay Maruti, et al.
Publicado: (2020)

Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose
por: Chin, Re-I, et al.
Publicado: (2022)

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
por: Ma, Sung Jun, et al.
Publicado: (2018)

How Do Patients Rate Their Radiation Oncologists in the Modern Era: An Analysis of Vitals.com
por: Randhawa, Simrath, et al.
Publicado: (2018)

Brachytherapy for malignancies of the vagina in the 3D era
por: Glaser, Scott M., et al.
Publicado: (2015)

Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
por: Ha, Hyerim, et al.
Publicado: (2021)

Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
por: Horne, Zachary D, et al.
Publicado: (2014)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

2207: A Phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer
por: Ezra Shabason, Jacob, et al.
Publicado: (2018)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer
por: Das, Rishi, et al.
Publicado: (2023)

Tumor Bed Radiosurgery Following Resection and Prior Stereotactic Radiosurgery for Locally Persistent Brain Metastasis
por: Holt, Douglas Emerson, et al.
Publicado: (2015)

Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma
por: Cho, Yeona, et al.
Publicado: (2020)

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies
por: Rixe, Olivier, et al.
Publicado: (2015)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

Proposed brachytherapy recommendations (practical implementation, indications, and dose fractionation) during COVID-19 pandemic
por: Mohindra, Pranshu, et al.
Publicado: (2020)

Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy
por: Lau, Sally C.M., et al.
Publicado: (2021)

Radiation dose ≥54 Gy and CA 19–9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation
por: Golden, Daniel W, et al.
Publicado: (2012)

Dose escalation of a curcuminoid formulation
por: Lao, Christopher D, et al.
Publicado: (2006)

Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas
por: Pompa, Tiffany A., et al.
Publicado: (2017)

Comparative study of concomitant chemoradiation versus concomitant chemoradiation followed by high-dose-rate intraluminal brachytherapy in locally advanced esophageal carcinoma: a single institutional study
por: Halder, Anirban, et al.
Publicado: (2018)

The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas
por: Rogers, S.J., et al.
Publicado: (2021)

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
por: Yamada, M, et al.
Publicado: (2002)

A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer
por: Prasad, Rahul N., et al.
Publicado: (2020)

The role of biological dose-escalation for pancreatic cancer
por: Bruynzeel, Anna M.E., et al.
Publicado: (2019)

Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma
por: Sutera, Philip A., et al.
Publicado: (2018)

Complete Pathologic Response Following Neoadjuvant Chemoradiotherapy and High-Dose-Rate Brachytherapy for Locally Advanced Endometrial Carcinoma
por: Horne, Zachary, et al.
Publicado: (2015)

Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study
por: Qing, Shui-Wang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_48bhl6m7qcr67nn5t9bji9dbi0